Track topics on Twitter Track topics that are important to you
Located in the north-east corner of the USA, Massachusetts, has the third highest GDP of any state in America and is also a hotspot for the biotechnology industry. In addition to the globally renown...
The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...
Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace
The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...
Surrounded by the Great Lakes in the north east of the US, Michigan hosts many high profile biotechnology companies and has become an industry hotbed. In 1993 MichBio was formed, as an industry tr...
Covidien is the 9th largest global medical device company with annual sales in 2010 of almost $8 billion. Covidien was originally Tyco Healthcare, until June 2007, and has seen year-on-year growth s...
Patients with Parkinson's disease in the UK can now potentially access a new option to treat motor fluctuations with the launch of Bial's Ongentys across the country.
Bial says that its Ongentys (opicapone) has now been launched in the UK for the treatment of adult Parkinson´s…
(MedPage Today) -- News and commentary from the world of neurology and neuroscience
In its safety review of fatty acid amide hydrolase (FAAH) inhibitors, FDA concluded that BIA 10-2474 from Bial-Portela & Ca. S.A. (S. Mamede do Coronado, Portugal) "exhibits a unique toxicity that doe...
SummaryBial Portela Ca, S.A. BIAL is a pharmaceutical company that discovers, develops and provides therapeutic solutions. The company offers products such as antiinflammatories, antidiabetics, card...
Drug company BIAL Pharm UK has launched opicapone (Ongentys), a new drug to improve mobility in some adult patients with Parkinson’s disease, for use in the UK.
There have been new revelations regarding the fatal French clinical trial that occurred in January of this year. Nature reports that in a conference call the company behind the trial, Portuguese compa...
Valeant Pharmaceuticals International subsidiary Dendreon Pharmaceuticals will be acquired by Sanpower Group.
Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...
The behavior and fate of pharmaceutical ingredients in coastal marine ecosystems is not well understood. To address this, the spatial and temporal distribution of 15 high volume pharmaceuticals were m...
For the ﬁrst time in its short history, our journal is able, this year, to support a young researcher in the ﬁeld of medicinal chemistry by offering a travel grant of 800 CHF.[...].
Recently pharmaceuticals have become significant environmental pollutants in aquatic ecosystems, that could affect primary producers such as microalgae. Here we analyzed the effect of pharmaceuticals ...